Jack Burks, M.D.
PRESENT POSITION:
President
Burks & Associates Health Care & Research Consulting Group
Plantation, Florida
Chief Medical Officer
Multiple Sclerosis Association of America
Cherry Hill, New Jersey
Clinical Professor
Department of Neurology
Herbert Wertheim College of Medicine
Florida International University
Miami, Florida
MAILING ADDRESS:
12621 NW 1st Place
Plantation, Florida 33325
Phone: (754) -701-5068
Fax: (754) -701-5250
E-mail: jack@jackburks.com
Website: www.jackburks.com
EDUCATION:
1961-1965
B.A., West Virginia University
1965-1969
M.D. (with honors)
West Virginia University
1969-1970
Internship: Internal Medicine
University of Cincinnati
1970-1973
Residency: Neurology
University of Colorado
1973-1975
Post Doctoral Fellowship:
Multiple Sclerosis
Virology and Immunology
Johns Hopkins University
LICENSURE:
Colorado, 1972
Maryland, 1974
California, 2001
Nevada, 2003
New Jersey, 2009
Florida, 2012
1
ACADEMIC APPOINTMENTS HELD:
1974 – 1975
Instructor in Neurology
Johns Hopkins University
1975 – 1981
Assistant Professor of Neurology
Assistant Professor of Microbiology and Immunology
University of Colorado Health Sciences Center
1978 – 1988
Institute Director (Direct Report to Chancellor, UCHSC)
Rocky Mountain MS Center
University of Colorado Health Sciences Center
1981 – 1988
Associate Professor of Neurology
University of Colorado, School of Medicine
1988 – 1998
Chief of Neurology
Swedish Medical Center, Englewood, Colorado
1995 – 1999
Clinical Associate Professor of Family Medicine
University of Colorado, School of Medicine
1999 – 2009
Clinical Professor of Medicine (Neurology)
University of Nevada, School of Medicine
2009 – 2010
Director of Program Development
Comprehensive MS Center, Holly Name Hospital, Teaneck, New Jersey
2012 – Present
Clinical Professor of Neurology
Herbert Wertheim College of Medicine
Florida International University
AWARDS, FELLOWS, GRANTS:
Alpha Omega Alpha, Medical Honor Society
American Cancer Society Fellowship
National Multiple Sclerosis Society Fellowship
Speedy Award, Paralyzed Veterans of America: Honored Nationally for contribution to Veterans
The Global Directory of “Who’s Who”, Professional of the Year 2007
"Who's Who in Colorado Health Care"
National MS Society Great Basin Chapter, Outstanding Medical Professional of the year
Multiple Sclerosis Association of America, Honored Lifetime contribution to MS
Several Awards from Service Organizations
Several University Lectureships/Visiting Professorships
2
PROFESSIONAL SOCIETY MEMBERSHIPS:
American Neurological Association
American Academy of Neurology (Fellow) (Past Executive Board Member)
American Society of Neurorehabilitation (Past President)
American College of Physician Executives (Life Member)
American Medical Association
Consortium of Multiple Sclerosis Centers (Past Secretary-Treasurer)
Colorado Medical Society: Delegate: Council Member
Florida Medical Association
Florida Society of Neurology
ACTIVITIES:
UNIVERSITY OF COLORADO HEALTH SCIENCES CENTER (selected Committees):
1975 – 1988
Institute Director (Rocky Mountain MS Center)
Medical School Executive Committee (ad hoc)
Medical Advisory Committee, Clinical Research Center
Tenure, Promotions, and Search Committees
Neurology Residency Committee, Chairman
DENVER VETERANS ADMINISTRATIVE MEDICAL CENTER (selected activities):
1975 – 1988
Director Neurovirology and Neuroimmunology Laboratory
Chairman, Research and Development Committee
Director, Multiple Sclerosis Comprehensive Care Clinic
MULTIPLE SLEROSIS SOCIETY OF COLORADO
1975 – 1991
Medial Director
VETERANS ADMINISTRATION NATIONAL COOPERATIVE STUDY IN ALS
1977 – 1978
Executive Planning Committee
ROCKY MOUNTAIN MULTIPLE SCLEROSIS CENTER (RMMSC), ENGLEWOOD, CO
1978 – 1998
Founder, President, CEO
WINTER CONFERENCE ON BRAIN RESEARCH (WCBR)
1978 – 1990
Organizing Committee
CLINICAL NEUROSCIENCE SOCIETY
1979 – 1980
President
AMERICAN ACADEMY OF NEUROLOGY (selected activities):
1973 – Present
Board of Directors (Executive Board)
Chair, Disease Management Initiative
Chair, Strategic Direction Task Force
Practice Committee
3
ACTIVITIES (continued)
Practice (Quality) Improvement Subcommittee
American Academy of Physical Medicine and Rehabilitation Joint Task Force
Ethics Committee
Committee on Chronic Care and Rehabilitation
Audit Committee
Investment Committee
Public Education Committee
Education and Research Foundation (ERF) Committee
Neurology Journal Reviewer
Chair of several Annual Meeting Scientific Sessions
Chairman, Section on Neurorehabilitation
Chair and Lecturer, Several Annual Meeting Courses
NATIONAL MS SOCIETY, New York, (selected activities):
1984 – Present
Medical Advisory Board, New York
Clinic Committee, New York
Education Committee, New York
Clinical Advisory Committee, Nevada
CONSORTIUM OF MS CENTERS (selected activities):
1985 – Present
Founding Board Member
Executive Committee
Board of Directors
Secretary/Treasurer
AMERICAN CONGRESS OF REHABILITATION MEDICINE/AMERICAN ACADEMY OF PHYSICAL
MEDICINE AND REHABILITATION
1987 – 2004
Multiple Sclerosis Task Force - with AAN
Director, Educational Courses on Multiple Sclerosis
COLORADO NEUROLOGICAL INSTITUTE (selected activities):
1988 – 1998
Founding Member, Executive Committee
Chair, Program Development and Outreach Committee
SWEDISH MEDICAL CENTER, ENGLEWOOD, COLORADO
1988 – 1998
Chief of Neurology
WESTERN ALLIANCE AGAINST MULTIPLE SCLEROSIS
1989 – 1993
Executive Committee
PHYSICALLY CHALLENGED ACCESS TO THE WOODS (PAW)
1990 – 1998
Board of Directors
4
ACTIVITIES (continued)
NATIONAL EASTER SEALS RESEARCH FOUNDATION
1990 – 1994
Trustee
INSTITUTE OF MEDICINE (IOM) AND CENTERS FOR DISEASE CONTROL (CDC)
1990 – 1991
Prevention of Primary and Secondary Disabilities in Chronic Illness Task Force
AMERICAN SOCIETY OF NEUROREHABILITATION
1991 – Present
Founding Board Member
President
Foundation Board of Directors
AUSTRIAN NEUROREHABILITATION SOCIETY
1997
Consultant
ARAPAHOE MEDICAL SOCIETY/COLORADO MECICAL SOCIETY
1994 – 1999
Council Member/Delegate
MS COUNCIL ON CLINICAL PRACTICE GUIDELINES
1997 – 2002
Founding Board Member & Chairman
Chair, Topic and Panel Selection Committee
AMERICAN BOARD OF PHYSICAL MEDICINE AND REHABILITATION AND AMERICAN BOARD OF
PSYCHIATRY AND NEUROLOGY
1997 – 2001
Advisory Group on Subspecialty Certification in Spinal Cord Medicine
MULTIPLE SCLEROSIS ALLIANCE (MSA), DENVER, CO
1998 – 2007
President
MS CHAMPIONS OF COURAGE (BOARD OF DIRECTORS)
1998 – 2007
WASHOE (RENOWN HEALTH) INSTITUTE FOR NEUROSCIENCES, RENO, NV
1999 – 2003
Founder, Medical Director
GERIATRIC MEDICAL ADVISORY BOARD
1999 – 2007
University of Nevada, Reno
NEUROSCIENCES JOURNAL
2007-2010
Editorial Board
5
PUBLICATIONS:
1.
Burks, J., Magaiolo, J., and Watne, A.: Tumor cells in the blood: Quantitative recovery by sedimentation
and hemolytic techniques. Acta Cytol. 1:92-7, 1967.
2.
Alfrey, A.C., Mishell, J.M., Burks, J., Contiguglia, S.R., Rudolph, H., Lewin, E., and Holmes, J.H.: Syndrome of dyspraxia and multifocal seizures associated with chronic hemodialysis. Trans. Amer. Soc. Artif. Inc. Organs 18:257-61, 1972.
3.
Burks, J.S., Walker, J.E., Rumack, B.H., and Ott, J.E.: Tricyclic anti-depressant poisoning: Reversal of
coma, choreoathetosis, and myoclonus by physostigmine. JAMA 230(10): 1405-7, 1974.
4.
Burks, J.S., Narayan, O., McFarland, H.F., and Johnson, R.T.: Acute encephalopathy caused by defective virus infection. I. Studies of Newcastle disease virus infections in newborn and adult mice. Neurolo-
gy 26(6):584-8, 1976.
5.
Miyamoto, H., Walker, J.E., Ginsberg, A.H., Burks, J.S., McIntosh, K., and Kempe, C.H.: Antibodies to
vaccinia and measles viruses in multiple sclerosis patients. Arch. Neurol. 33(6):414-7, 1976.
6.
Burks, J.S., Alfrey, A.C., Huddlestone, J., Norenberg, M.D., and Lewin, E.: A fatal encephalopathy in
chronic hemodialysis patients. Lancet 1(7963):764-8, 1976.
7.
Austin, J.H., Burks, J.S., Earnest, M.P., Hoehn, M.M., Lewin, E.D., Lewis, J.A., Quintero, P.S., Ringel,
S.P., Schneck, S.A., et al.: Chapter 7. Neurology. Clinical Internal Medicine. L.B. Reller, S.A. Sah, and
R.W. Schrier, (eds.) Little, Brown & Company, Boston, 1979.
8.
Bondy, S.C., Burks, J.S., and Harrington, M.E.: Uptake and release of putative neuro-transmitters: Meas-
urements in regions of the normal and Newcastle disease virus infected mouse brain. Arch. Neurol.
36:540-3, 1979.
9.
Burks, J.S., Murray, R.S., Naylor, J., Jankovsky, L.D., and Bondy, S.C.: RNA synthesis in normal and
Newcastle disease virus infected mice. J. Neurochem. 32:633-5, 1979.
10. Burks, J.S., Harrington, M.E., and Bondy, S.C.: The supply of nutrients to the normal and Newcastle disease virus infected mouse brain. Neurotoxicology 1(2):417-23, 1979.
11. Burks, J.S., DeVald, B., Jankovsky, L., Gerdes, J.: A possible Coronavirus isolation from multiple sclerosis autopsy material. Progress in Multiple Sclerosis Research. H.J. Bauer, S. Poser, G. Ritter, (eds.)
Springer-Verlag, New York, 1980.
12. Smith, D.B., Lewis, J.A., Burks, J.S., and Alfrey, A.C.: Dialysis encephalopathy in peritoneal dialysis. JAMA 244(4):365-6, 1980.
13. Burks, J., DeVald, B., Jankovsky, L., Gerdes, J.: Two coronaviruses isolated from central nervous system
tissue of two multiple sclerosis patients. Science 209(4459):933-4, 1980.
14. Burks, J.S.: An overview of multiple sclerosis. The Rehabilitation of Multiple Sclerosis and Neuromuscular Disorders. J.S. Burks and F.P. Maloney, (eds.) Denver, Colorado, 1981.
6
15. Gerdes, J.C., Jankovsky, L.D., DeVald, B.L., Klein, I., and Burks, J.S.: Antigenic relationships of coronaviruses detectable by plaque neutralization, competitive enzyme linked immunoabsorbent assay, and immunoprecipitation. Advances in Experi-mental Medicine and Biology. V. ter Meulen, (ed.) 142:29-41,
1981.
16. Gerdes, J.C., Klein, I., DeVald, B.L., and Burks, J.S.: P Coronavirus isolates SK and SD from multiple
sclerosis patients are serologically related to murine coronaviruses A59 and JHM and human coronavirus
OC43 but not to human coronavirus 229E. J. Virology 38(1):231-8, 1981.
17. Wendt, J.S. and Burks, J.S.: An unusual case of encephalomyeloradiculo-neuropathy in a young woman.
Arch. Neurol. 38(11):726-7, 1981.
18. Gerdes, J.C., McNally, I., Hileman, L., and Burks, J.S.: Autoradiographic detection of IgG and viral antigens. J. Immunol. Methods. 54(2):191-202, 1982.
19. Burks, J.S and Thompson, D.S.: Multiple sclerosis. Neurological Emergencies. Churchill Livingston, New
York, 1983.
20. Murray, R.S., Burks, J.S., Smyth, W.R., Miller, N., Alfrey, A.C., Gerdes, J.C.: Elemental analysis in murine central nervous system: Elevation of rubidium subsequent to Newcastle disease virus encephalopathy. J. Neurochem. 41(4):1011-15, 1983.
21. Mendelman, P.M., Jankovsky, L.D., Murray, R.S., Licari, P., DeVald, B., Gerdes, J.C., Burks, J. S.: Pathogenesis of coronavirus SD in mice. I. Prominent demyelination in the absence of infectious virus production. Arch. Neurol. 40(8):493-8, 1983.
22. Kemp, M.C., Hierholzer, J.C., Burks, J.S.: Characterization of viral proteins synthe-sized in 229E-infected
cells and effect(s) of inhibition of glycosialiation and glycoprotein transport. Advances in Experimental
Medicine and Biology. P. Rottier. 173:65-78, 1984.
23. Burks, J.S., Jankovsky, L., Licari, P.A., McNally, I.T., and Kemp, M.C.: Immunosuppression with Cyclophoshamide does not prevent demyelination or result in uncontrolled viral replication in coronavirus SDinfected mice. Advances in Experimental Medicine and Biology. P. Rottier. 173:277-8, 1984.
24. DeVald, B.L., Gerdes, J.C., Burks, J.S., and Kemp, M.C.: Amphotericin inhibits coronavirus SD, SK and
A59 growth. Advances in Experimental Medicine and Biology. P. Rottier. 73:151-2, 1984.
25. Jankovsky, L., Mendelman, P., DeVald, B.L., Gerdes, J.C., Licari, P., Kemp, M.C., and Burks, J.S.:
A one-year study of coronavirus SD infection in mice. Advances in Experimental Medicine and Biology.
P. Rottier. 173:271-6, 1984.
26. Burks, J.S., DeVald, B.L. Gerdes, J.C., McNally, I.T., and Kemp M.C.: Failure to detect coronavirus SK
antigen in multiple sclerosis brain tissue by autoradiography. Advances in Experimental Medicine and
Biology. P. Rottier. 173:393-4, 1984.
27. Kemp, M.C., Harrison, A., Hierholzer, J.C., and Burks, J.S.: Electron lucent structures induced by corona
viruses. Advances in Experimental Medicine and Biology. P. Rottier. 173:153-4, 1984.
7
28. Kemp, M.C., Harrison, A., Hierholzer, J.C., and Burks, J.S.: Assembly of 229E virions in human embry-
onic lung fibroblasts and effects of inhibition of glycosialiaion and glycoprotein transport. Advances in
Experimental Medicine and Biology. P. Rottier. 173:65-7, 1984.
29. Franklin, G.M. and Burks, J.S.: Viral meningoencephalitis. Conn's Current Thera-py. R.E. Rakel (ed.)
W.B. Saunders Co., Philadelphia, 1984.
30. Haase, A.T., Stowring, L., Ventura, P., Burks, J., Ebers, G., Tourtellotte, W., and Warren, K.: Detection
by hybridization of viral infection of the human central nervous system. Ann. N.Y. Acad. Sci. 436:103-8,
1984.
31. Cobble, N.D. and Burks, J.S.: The team approach to the management of multiple sclerosis. Interdisciplinary Rehabilitation of Multiple Sclerosis and Neuromuscular Disorders. F.P. Maloney, J.S. Burks,
and S.P. Ringel, (eds.) J.B. Lippincott Company, New York, 1985.
32. Franklin, G.M. and Burks, J.S.: Diagnosis and medical management of multiple sclerosis.
Interdiscipli-
nary Rehabilitation of Multiple Sclerosis and Neuromuscular Disorders. F.P. Maloney, J.S. Burks, and
S.P. Ringel, (eds.) J.B. Lippincott Company, New York, 1985.
33. Heaton, R.K., Nelson, L.M., Thompson, D.S., Burks, J.S., and Franklin, G.M.: Neuro-psychological findings in relapsing/remitting and chronic/progressive multiple sclerosis. J. Consult. Clin. Psychol. 53
(1):103-10, 1985.
34. Nelson, L.M., Hamman, R.F., Thompson, D.S., Baum, H.M., Boteler, D.L., Burks, J.S., and Franklin,
G.M.: Higher than expected prevalence of multiple sclerosis in northern Colorado: Dependence on
methodologic issues. Neuroepidemiology 5(1):17-28, 1986.
35. Thompson, D.S., Nelson, L.M., Burns, A., Burks, J.S., and Franklin, G.M.: The effects of pregnancy in
multiple sclerosis: A retrospective study. Neurology 36(8):1097-9, 1986.
36. Hauser, S.L., Aubert, C., Burks, J.S., Kerr, C., Lyon-Caoen, O., de The, G., and Brahic, M.: Analysis of
human T-lymphotropic virus sequences in multiple sclerosis tissue. Nature 322(6075):176-7, 1986.
37. Burks, J.S.: How to get the most from your doctor: A neurologist’s perspective. Paraplegia News. 40-3,
1987.
38. Rosenberg, N.L., Kotzin, B.L., Kemp, M.C., Burks, J.S., and Santoro, T.J.: Corona-virus SD-induced
immunoregulatory disturbances in a murine model of demyelination. Advances in Experimental Biology. Lai, M. and Stohlman, S.A., (eds.) 1987.
39. Murray, R.S., MacMillan, B., and Burks, J.S.: Coronavirus SD genome in central nervous system tissue
from multiple sclerosis and controls. Neurology 37(1):109, 1987.
40. Haffler, D., Benjamin, D., Burks, J., and Weiner, H.: Myelin basic protein and proteo-lipid protein reactivity of brain cerebrospinal fluid derived T cell clones in multiple sclerosis and post infectious encephalomyelitis. J. Immunol. 139:68-72, 1987.
8
41. Cobble, N.D., Wangaard, C., Kraft, G., and Burks, J.S.: Rehabilitation of the patient with multiple sclerosis. Principles and Practice of Rehabilitation Medicine. J.A. Delisa, D. Currie, B. Gans, P. Gatens, J.A.
Leonard, and M. McPhee, (eds.) J.B. Lippincott, Philadelphia, 1988.
42. Nelson, L.M., Franklin, G.M., Hamman, R.F., Boteler, D.L., Baum, H.M., and Burks, J.S.: Referral bias in
multiple sclerosis research. Journal of Clinical Epidemiology 41:187-92, 1988.
43. Fleming, J.O., Zaatari, F.E., Gilmore, W., Berne, J., Burks, J.S., Stohlman, S.A., Tourtellotte, W.W., and
Weiner, L.P.: Antigenic Assessment of Coronaviruses Isolated from Patients with Multiple Sclerosis.
Arch. Neurol. 45:629-33, 1988.
44. Franklin, G.M., Nelson, L.M., Heaton, R.K., Burks, J.S., and Thompson, D.S.: Stress and its relationship
to acute exacerbations in multiple sclerosis (MS). J. Neuro Rehab. 2:7-11, 1988.
45. Hayashi, T., Morimoto, C., Burks, J.S., Kerr, C., Hauser, S.L.: Double-Label Immuno-cytochemistry of the
Active MS Lesion: Major Histocompatibility Complex and Activa-tion Antigens. Ann Neurol. 24:523-31,
1988.
46. Hayashi T, Burks JS, Hauser SL. Expression and cellular localization of major histocompatibility complex
antigens in active multiple sclerosis lesions. Ann N Y Acad Sci. 540:301-5. 1988
47. Burks, J.S., Gellerman, E., Licari, P.: Multiple Sclerosis: The Team Approach. Paraplegia News. 28-30,
1989.
48. Filley, C.M., Heaton, R.K., Nelson L.M., Burks, J.S., Franklin, G.M.: A Comparison of Dementia in Alzheimer's Disease and Multiple Sclerosis. Arch Neurol. 6(2):157-61, 1989.
49. Murray RS, MacMillan B, Cabirac G, Burks JS. Detection of coronavirus RNA in CNS tissue of multiple
sclerosis and control patients. Adv Exp Med Biol. 276:505-10,1990
50. Cobble, N., Burks, J.S.: Introduction to Principles of Rehabilitation. J Neuro Rehab. 4:181-5, 1990.
51. Multiple Sclerosis Study Group: Efficacy and Toxicity of Cyclosporine in Chronic Progressive Multiple
Sclerosis: A Randomized, Double-blinded, Placebo-controlled Clinical Trial. Ann Neurol. 27(6): 591-605,
1990.
52. Murray, R.S., MacMillan, B., Cabirac, G.C., Burks, J.S.: The detection of coronavirus RNA in the CNS of
MS and control patients. Coronaviruses and Their Diseases: Advances in Exp Med Biol. 276:505-10, D.
Cavanaugh and TDK Brown, (eds.) Plenus Press, New York, 1991.
53. Burks, J.S.: A Dynamic Model for Understanding the Physician's Relationship with Patients and Their
Families. Multiple Sclerosis and The Family. Kalb, R.C. and Scheinberg, L.C. (eds.) Demos, New York.
1992.
54. Burks, J.S.: The financial and legal implications of multiple sclerosis for the family. Multiple Sclerosis and
The Family. Kalb, R.C. and Scheinberg, L.C. (eds.) Demos, New York. 1992.
55. Bourdette, D.N., Prochazka, A.V., Mitchell, W., Licari, P., Burks, J., et al: Health Care Costs of Veterans
with Multiple Sclerosis: Implications for the Rehabilitation of MS. Arch. Phys. Med. Rehabil. 74:26-31,
1993.
9
56. Burks, J.S.: Multiple Sclerosis, Conn’s Current Therapy. Rakel, R. (ed.) Philadelphia: W.B. Saunders Co.,
1993.
57. Burks, J.S.: How to Talk to Your Doctor. Inside MS. Winter/Spring; 5-6, 1994.
58. Burks, J.S.: Rehabilitation of Multiple Sclerosis Patients with Spinal Cord Dysfunction Compared to Spinal Cord Injury Patients. J.Neuro Rehab. 8(1):17-24, 1994.
59. Halper, J., Burks, J.S.: Care Patterns in Multiple Sclerosis: Principal Care, Compre-hensive Team Care,
Consortium Care. NeuroRehab 4(2):67-75, 1994.
60. Namerow, N.S., Anderson, L., Burks, J.S.: Resources: The American Society of Neurorehabilitation.
Rehab Management 7(3):13, 1994.
61. Burks, J.S., Halper, J., Daigh, R., Daily, P., et al.: Managing Chronic Disease Under Health Care Reform.
Rehab Management 7(4)49-51, 53, 1994.
62. Halper, J., Burks, J.S., LaRocca, N.G.: What Do We Know About MS Care? A Conference. J. Neuro Rehab. 8(3):99-103, 1994
63. Schwartz, C.E., Burks, J.S., Vickrey, B., Cole, B., Gelber, R.: The Q-Twist Approach to Assessing Health
-Related Quality of Life in Epilepsy. Quality of Life Research, 4(2):135-41, 1995.
64. Lublin, F.D., Whitaker, J.N., Eidelman, B.H., Miller, A.E., Arnason, B.G.W., Burks, J.S., Management of
patients receiving interferon beta 1b for multiple sclerosis. Neurology, 46(1):12-18, 1996.
65. Burks, JS, The Neuroimmunology of Multiple Sclerosis, Advances in Neuroimmunology. 6(2):143-54,
1996.
66. Coulthard-Morris, L., Burks, J.S., Herndon, R.: Scales for Assessment of Rehabilitation, Handbook of
Neurological Ratings Scales. Herndon, R. (ed.) Demos, 1997.
67. Burks, J.S.: An Algorithm Approach to MS, CNI Review. 7(1):11-16, 1996.
68. Lublin F, Whitaker J, Eidelman B, Miller A, Arnason B, Burks J. Management of patients receiving interferon beta-1b for multiple sclerosis: report of a consensus conference. Neurology 46(1):12-8, 1996
69. Burks, J.S., The Family Relationship with the Physician/Healthcare Team. Multiple Sclerosis and the
Family, R. Kalb (ed.) Demos, 1997
70. Shaughnessy, L., Schuchman, M., Ghumra, M., Daily, P., Burks, J.S.: Sexual Dysfunction in Multiple
Sclerosis. Sexual and Reproductive Neuro Rehabilitation. Humana Press, 1997.
71. Burks, J.S., Multiple Sclerosis Care: An integrated Disease Management Model. Journal of Spinal Cord
Medicine. 21(2):113-6, 1998.
72. Burks, Jack. Is Case Management the Solution to the Managed Care Conundrum? MS Quarterly. 17
(2):4-7, 1998.
73. Burks, Jack. Multiple Sclerosis: A Unique Challenge in Disease Management. Disease Management. 3
(3):159-16, 1998.
10
74. Burks, J.S.: A Review of the Current Medical Aspects of Multiple Sclerosis. J. Neuro. Rehab. 6:131-9,
1999.
75. Ku YTE, Montgomery, L.D., Wenzel, K.C., Webbon B.W., Burks, J.S. Physiological and thermal responses of patients with MS to head and neck cooling. Am. J Phys. Med. Rehabil. 78(5): 447-56, 1999.
76. Burks, J.S.: Multiple Sclerosis: A Guide for Families, Second Edition. R Kalb (ed.) Demos, New York
1999
77. Brittell, L., Burks, J.S., Schapiro, R.: Symptom Management and Rehabilitation in MS. Multiple Sclerosis;
Diagnosis, Medical Management and Rehabilitation. Burks, J.S., and Johnson, K., ( eds.) Demos, New
York, 2000.
78. Brittell, L., Burks, J. S.: Alternative Medicine in Multiple Sclerosis. Multiple Sclerosis: Diagnosis, Medical
Management and Rehabilitation. Burks, J.S. and Johnson, K. (eds.) Demos, New York, 2000.
79. Burks, J.S., Bigley, G.K., Hill, H., Multiple Sclerosis: Impact on the Elderly. Behavioral Neurology in the
Elderly. Leon-Carrion, J. and Giannini, M. (eds.) CRC Press, Washington DC. 2002
80. Schapiro, R.T., Burks, J.S., Kinkel, R.P., Rammohan, K.W., Krupp, L.B., Van Den Noort, S., Zwibel, H.:
Pharmacologic Therapy for MS-Related Fatigue. Int J MS Care. (Oct supp;):6-7, 2002
81. Burks JS, Arnason BG, Coyle PK, Ford CC, et al.: Issues and practices in multiple sclerosis.
Nuerorehabil Neural Repair 16(4):307-20, Dec 2002
82. Burks, J.S., Bigley, G.K., Hill, H.: Multiple Sclerosis. Spinal Cord Medicine. Lin, V. (ed.) Demos, New
York. 2003
83. Burks, J.S. Interferon-β1b for multiple sclerosis. Expert Review of Neurotherapeutics. Mar; Vol. 5(2),
2005
84. Burks, J.S.: A practical Approach to immunomodulatory therapy of MS. Phys Med Rehabil Clin N Am.
16;449-466, 2005
85. Burks, J.S.: The changing face of multiple sclerosis and disease modifying therapies. Business Briefing:
US Neurology Review. 51-56, 2005
86. Burks, J.S.: Multiple Sclerosis: A Guide for Families, Third Edition. R. Kalb (ed.) Demos, New York, 2006
87. Burks, J.S., Noronha, A.: Guidelines on use of anti-IFN-B antibody measurements in multiple sclerosis:
report of an EFNS Task Force on IFN-B antibodies in multiple sclerosis. Letter to the Editor, European
J of Neurol. 14:e8-e9, 2007
88. Courtney, SW., Blank, R., Burks, J.S.: Partners in Wellness: The Importance of a Positive Doctor-Patient
Relationship. The Motivator. Spring;4-19, 2008
89. Montague A., Rapp B., Bechtel M., Ringer R., Burks J.: The Impact of Magnetic Resonance Imaging
Testing on MS Patients’ Treatment Decisions, Adherence to Medication and in the Management of Their
Overall Healthcare. Int’l J of MS Care. 10:(1);25-26, 2008
11
90. Burks, J.S.: MS: The Treatment Paradigm, A Pathway to Success for Improved Patient Outcomes.
JMCM. Vol 12 (1):26-31, 2008
91. Burks J.S., Bigley G.K., Hill H.: Rehabilitation Challenges in multiple Sclerosis. Ann Indian Acad Neurol. 12 (4):296-306, 2009
92. Burks, J.S., Bigley G.K., Hill H.: Multiple Sclerosis. Spinal Cord Medicine, Second Edition. Lin, V. (ed)
Demos, New York, 2010
93. Burks, J., Role of Biologic Response Modifiers in Autoimmune Diseases and the Impact on Multiple
Sclerosis: A Neurologist’s Perspective. Case Study 1. American Health & Drug Benefits Vol 3(1); Suppl
4; S48, 2010
94. Denys P., Bates D., Burks J.S, Chancellor M., Signori M., Globe D., Fitz-Randolph M., Hudgens S.:
Methodology and validation of urinary incontinence in multiple sclerosis screening tool. European J of
Neuro. 18(Suppl. 2):523, 2011
95. Burks, J.S., Kennelly M., Rovner E., Signori M., Globe D.: Health-Related Quality of Life in Patients
With Neurogenic versus Idiopathic Overactive Bladder. Mult Scler. 17(S10):S253, 2011
96. O’Shanick G., Page S., Jensen A., Burks J., Formella A.: Burden of Pseudobulbar Affect Among Patients With Multiple Sclerosis, Stroke, and Brain Injury: Results from National Patient Survey. Neurology. 78:P03.153, 2012
97. Ellsworth P., Coyle P., Esquenazi A., Anderson K.E., Burks J.S., Halper J., et al.: Consensus Statement
on Neurogenic Detrusor Overactivity: Review Multiple Sclerosis and Spinal Cord Injury; CME. UroTo-
day Int J. Mar;5(suppl 1), 2012
98. Ellsworth P., Coyle P., Esquenazi A., Anderson K.E., Burks J.S., Halper J., et al.: Improving Bladder
Care for Patients with Multiple Sclerosis and Spinal Cord Injury. Clinical Neurology News, Best Practices Supplement. June 2012. Available at: http://imn.globalacademycme.com/cme-library/
supplements.html
99. Coyle P, Burks J.: Levels of Evidence required to determine the benefit of treating CCSVI to Alleviate
symptoms of MS-A Neurology Perspective. Endovascular Today. 7(11):41-50; July 2012
100. Miller A., Burks J., Victor T., Zhou S., Jhaveri M., Fredane L.: Benefit/Risk evaluation of multiple sclerosis treatments by patients and physicians. Int’l J of MS Care. 14(2);37, 2012
101. Burks J., Malangone E., Jhaveri M., Zhou S., Bhurke S., Casciano R.: The Clinical Outcomes Associated with Adherence to and Discontinuation of Disease-modifying Treatments. Mult Scler. 18:(S4)318,
2012
12
102. Burks, J., Chancellor, M., Bates, D., Denys, P., DeRidder, D., MacDiarmid, S., Nitti, V., Globe, D. Si-
gnori, M., Hudgens, S., Odderson, I., Panicker, J., Perrin Ross, A.: Development and Validation of the
Actionable Multiple Sclerosis Bladder Health Screening Tool. Int’l J of MS Care. Accepted November
2012.
103. Bates, D., Burks, J. Globe, D., Signori, M., Hudgens, S. Denys, P., MacDiarmid, S., Nitti, V., Odderson,
Ib, Perrin Ross, A., Chancellor, M.: Development of a Short Form and Scoring Algorithm from the Validated Actionable Multiple Sclerosis Bladder Health Screening Tool. BMC Neurol. 2013 Jul 9;13(1):78
104. Kristin M. Khalaf, Karin S. Coyne, Denise R. Globe, Edward P. Armstrong, Daniel C. Malone, and Jack
Burks (2014) Lower Urinary Tract Symptom Prevalence and Management Among Patients with Multiple Sclerosis. International Journal of MS Care In-Press.
105. Khalaf, K.M., Coyne, K.S., Globe, D.R., Malone, D.C., Armstrong, E.P., Patel, V., Burks, J.:The Impact
of Lower Urinary Tract Symptoms on Health-Related Quality of Life Among Patients With Multiple
Sclerosis, Neurourology and Urodynamics DOI 10.1002/nau
106. Khalaf, K.M., Coyne, K.S., Globe, D.R., Malone, D.C., Armstrong, E.P., Patel, V., Burks, J.: The incremental impact of overactive bladder among patients with multiple sclerosis. Submitted to Multiple
Sclerosis
13
WEBCASTS:
1.
Burks J., Sommers R. MS Learn Online Feature Presentation MS 101 Webcast. National MS Society.
www.nationalmssociety.org/multimedia-library/ms-learn-online/ms-learn-online-basic-facts-of-ms/
index.aspx/ March 2010
2.
Burks J. A closer look—Multiple Sclerosis Symptom, Part 1 Webcast. Multiple Sclerosis Association of
America. http://mymsaa.org/manage-your-ms/videos/closerlook-1/ 2008
3.
Burks J. A closer look at The Importance of MS Treatment Adherence. Multiple Sclerosis Association of
America. http://mymsaa.org/manage-your-ms/videos/ 2008
4.
Burks J. A closer look at Clinically Isolated Syndrome and MS. Multiple Sclerosis Association of Ameri-
ca. http://mymsaa.org/manage-your-ms/videos/closerlook-7/ 2008
5.
Burks J. A closer look at Gilenya—The First Oral Treatment for Multiple Sclerosis Webcast. Multiple
Sclerosis Association of America. http://mymsaa.org/manage-your-ms/videos/closerlook-10/ Sept 2010
6.
Bethoux F., Burks J. Maintaining Quality of Life in Multiple Sclerosis: Strategies for Interdisciplinary Medicine and Rehabilitative Management and Improving the Provider-Patient Relationship. Neuroscience,
CME Webcast. www.neurosince.com/cmea.asp?ID=573/ July 2011
7.
Burks, J.: MS and Quality of Life, a Clinical Context Report. Medpage Today. www.medpagetoday.com/
clinical-context/MultipleSclerosis/31780/ Apr 2012
8.
MS Therapy Update (Part 1) with Jack Burks, MD - 2014 MSF Cruise for a Cause, https://
www.youtube.com/watch?v=-UjgMBP5bWk
9.
MS Therapy Update (Part 2) including PPMS with Dr. Jack Burks - 2014 MSF Cruise for a Cause, https://
www.youtube.com/watch?v=3oTc-EhATUIhttps://www.youtube.com/watch?v=MewfbrRusSM
10. Jack Burks, MD and Jennifer Falk - Symptom Management - September 2014, https://www.youtube.com/
watch?v=MewfbrRusSM
11. Jack S. Burks,-June 7th, 2014 - in Atlanta, Ga. - MS Treatment Options, Adherence, Switching, etc,
https://www.youtube.com/watch?v=JeQD7Xe2H3w
12. Jack S. Burks, MD – Emerging MS Therapies & MS Relapse -October 25th 2014 - MS Views & News 5th
Annual MS Symposium - Part 1, https://www.youtube.com/watch?v=l5g8oE_q5gw
13. Jack S. Burks, MD-Nov 8th 2014 - Emerging Therapies & INVISIBLE SYMPTOMS, https://
www.youtube.com/watch?v=A6oXFUISVF8
14
TEXTBOOKS WRITTEN/EDITED:
Maloney, F.P., Burks, J.S., and Ringel, S.P. (eds.) Interdisciplinary Rehabilitation of Multiple Sclerosis
and Neuromuscular Disorders. J.B. Lippincott Company, New York, 1985.
Burks, J., and Johnson, K. (eds.) Multiple Sclerosis; Diagnosis, Medical Management and Rehabilitation.
Demos, New York, 2000.
Holland, N.J., Burks J.S., Schneider D.M. (eds.) Primary Progressive Multiple Sclerosis: What You Need
to Know. DiaMedica, New York, 2010
RESEARCH:
Principal investigator on grants in Virology, Immunology, Rehabilitation, and Clinical Trials
1965-Present
INTERNATIONAL LECTURER:
Lecturer on Multiple Sclerosis, Comprehensive Care and/or Neurological Institute Development in over 40
countries on 6 continents
PATIENT RELATED ACTIVITIES:
Written/Edited hundreds of lay articles on Multiple Sclerosis
“Ask the Doctor” column in “the Motivator” for the Multiple Sclerosis Association of America
15